Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

E. Ko · SciRah

Researcher profile · Semantic Scholar

E. Ko

Share profile

E. Ko — researcher profile on SciRah

h-index: 19
Works: 54
Citations: 1,261

Most-cited papers

The Integration of Radiotherapy with Immunotherapy for the Treatment of Non–Small Cell Lung Cancer
E. Ko, D. Raben, S. Formenti
2018Clinical Cancer Research220 citations Open access
Semantic Scholar
Targeting Immune Suppressing Myeloid-Derived Suppressor Cells in Oncology
J. Kao, E. Ko, S. Eisenstein, Andrew G. Sikora +2 more
2010Critical reviews in oncology/hematology137 citations Open access
Semantic Scholar
Radiotherapy and checkpoint inhibitors: a winning new combination?
E. Ko, S. Formenti
2018Therapeutic Advances in Medical Oncology101 citations Open access
Semantic Scholar
Myeloid-Derived Suppressor Cells as an Immune Parameter in Patients with Concurrent Sunitinib and Stereotactic Body Radiotherapy
Hui‐ming Chen, Ge Ma, N. Gildener-Leapman, S. Eisenstein +12 more
2015Clinical Cancer Research98 citations Open access
Semantic Scholar
Epidemiology of Head and Neck Squamous Cell Cancer Among HIV-Infected Patients
G. D'Souza, T. Carey, W. William, M. Nguyen +10 more
2014Journal of Acquired Immune Deficiency Syndromes79 citations Open access
Semantic Scholar
Phase II Trial of Concurrent Sunitinib and Image-Guided Radiotherapy for Oligometastases
Charles C. L. Tong, E. Ko, M. Sung, J. Cesaretti +10 more
2012PLoS ONE72 citations Open access
Semantic Scholar
Radiation therapy to enhance tumor immunotherapy: a novel application for an established modality
E. Ko, S. Formenti
2019International Journal of Radiation Biology68 citations
Semantic Scholar
Generating antitumor immunity by targeted radiation therapy: Role of dose and fractionation
E. Ko, K. Benjamin, S. Formenti
2018Advances in Radiation Oncology58 citations Open access
Semantic Scholar
Targeting Melanoma Cells with Human High Molecular Weight-Melanoma Associated Antigen-Specific Antibodies Elicited by a Peptide Mimotope: Functional Effects
W. Luo, E. Ko, J. Hsu, Xin-Hui Wang +1 more
2006Journal of Immunology41 citations Open access
Semantic Scholar
PSA nadir of <0.5 ng/mL following brachytherapy for early-stage prostate adenocarcinoma is associated with freedom from prostate-specific antigen failure.
E. Ko, N. Stone, R. Stock
2012International Journal of Radiation Oncology, Biology, Physics36 citations
Semantic Scholar
Differential Immunogenicity of Two Peptides Isolated by High Molecular Weight-Melanoma-Associated Antigen-Specific Monoclonal Antibodies with Different Affinities1
W. Luo, J. Hsu, Chun-yen Tsao, E. Ko +2 more
2005Journal of Immunology29 citations
Semantic Scholar
Enhancement of scFv fragment reactivity with target antigens in binding assays following mixing with anti-tag monoclonal antibodies.
Xin-Hui Wang, Michael R. Campoli, E. Ko, W. Luo +1 more
2004JIM - Journal of Immunological Methods29 citations
Semantic Scholar
Immunotherapy of Malignant Diseases
E. Ko, Xin-Hui Wang, S. Ferrone
2003International Archives of Allergy and Immunology28 citations
Semantic Scholar
Radiobiological rationale and clinical implications of hypofractionated radiation therapy.
E. Ko, Kevin Forsythe, M. Buckstein, J. Kao +1 more
2011Cancer Radiothérapie26 citations
Semantic Scholar
Mouse dendritic-endothelial cell hybrids and 4-1BB costimulation elicit antitumor effects mediated by broad antiangiogenic immunity.
E. Ko, W. Luo, Liao-Min Peng, Xin-Hui Wang +1 more
2007Cancer Research26 citations Open access
Semantic Scholar
Human high molecular weight melanoma-associated antigen mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: enhancement of immunogenicity of anti-idiotypic monoclonal antibody MK2-23 by fusion with interleukin 2.
Xin-Hui Wang, E. Ko, Liao-Min Peng, S. Gillies +1 more
2005Cancer Research25 citations Open access
Semantic Scholar
γ-H2AX Kinetics as a Novel Approach to High Content Screening for Small Molecule Radiosensitizers
S. Fu, Ying Yang, Das Tirtha, Yen Yun +8 more
2012PLoS ONE24 citations Open access
Semantic Scholar
Radiotherapy and Immunotherapy Combinations for Lung Cancer
V. Agrawal, K. Benjamin, E. Ko
2020Current Oncology Reports22 citations
Semantic Scholar
Combined Inhibition of Epidermal Growth Factor Receptor and Cyclooxygenase-2 as a Novel Approach to Enhance Radiotherapy
S. Fu, M. Rivera, E. Ko, Andrew G. Sikora +8 more
2011Journal of Cell Science & Therapy21 citations Open access
Semantic Scholar
Tolerability, Toxicity, and Temporal Implications of Transoral Robotic Surgery (TORS) on Adjuvant Radiation Therapy in Carcinoma of the Head and Neck
T. Carpenter, B. Kann, M. Buckstein, E. Ko +5 more
2014Annals of Otology, Rhinology and Laryngology15 citations
Semantic Scholar
Toxicity profile and clinical outcomes in locally advanced head and neck cancer patients treated with induction chemotherapy prior to concurrent chemoradiation.
E. Ko, E. Genden, K. Misiukiewicz, P. Som +4 more
2011Oncology Report15 citations Open access
Semantic Scholar
CD4-Dependent Potentiation of a High Molecular Weight-Melanoma-Associated Antigen-Specific CTL Response Elicited in HLA-A2/Kb Transgenic Mice1
Liao-Min Peng, E. Ko, W. Luo, Xin-Hui Wang +2 more
2006Journal of Immunology14 citations
Semantic Scholar
P2.04-92 Neoadjuvant Durvalumab With or Without Sub-Ablative Stereotactic Radiotherapy (SBRT) in Patients with Resectable NSCLC (NCT02904954)
N. Altorki, A. Borczuk, A. Saxena, J. Port +13 more
2019Journal of Thoracic Oncology13 citations Open access
Semantic Scholar
Treatment strategies in low-volume metastatic castration-resistant prostate cancer
Xiao X. Wei, E. Ko, C. Ryan
2017Current Opinion in Urology13 citations
Semantic Scholar
Correction: γ-H2AX Kinetics as a Novel Approach to High Content Screening for Small Molecule Radiosensitizers
S. Fu, Ying Yang, Tirtha K. Das, Yen Yun +8 more
2012PLoS ONE12 citations Open access
Semantic Scholar
Prognostic significance of p16 in locoregionally advanced head and neck cancer treated with concurrent 5-fluorouracil, hydroxyurea, cetuximab and intensity-modulated radiation therapy.
Charles C. L. Tong, K. H. Vincent Lau, M. Rivera, D. Cannan +11 more
2012Oncology Report11 citations Open access
Semantic Scholar
Partial vs. whole breast irradiation in a community hospital: a retrospective cohort analysis of 200 patients.
E. Ko, C. Koprowski, D. Dickson-Witmer, E. Penman +5 more
2010Brachytherapy11 citations
Semantic Scholar
First Report of NRG Oncology RTOG 0622: A Phase II Trial of Samarium-153 Followed by Salvage Prostatic Fossa Irradiation in High-Risk, Clinically Non-Metastatic Prostate Cancer after Radical Prostatectomy
R. Valicenti, S. Pugh, E. Trabulsi, O. Sartor +7 more
2017International Journal of Radiation Oncology, Biology, Physics5 citations Open access
Semantic Scholar
Postoperative Radiation After Radical Prostatectomy.
E. Ko, A. Michaud, R. Valicenti
2017Seminars in Radiation Oncology4 citations
Semantic Scholar
Association of early PSA failure time with increased distant metastasis and decreased survival in prostate brachytherapy patients.
E. Ko, Jerry Liu, N. Stone, R. Stock
2014Radiotherapy and Oncology4 citations
Semantic Scholar
The Future of Proton Therapy
T. Fitzgerald, L. Ding, C. Riberdy, Jack Bailey +19 more
2021Proton Therapy - Current Status and Future Directions2 citations Open access
Semantic Scholar
Radiation unlocks the therapeutic potential of immune checkpoint blockers in lung cancer patients
E. Ko, L. Galluzzi
2019Oncoimmunology2 citations Open access
Semantic Scholar
Mismatch Repair Status in the Endometrial Cancer Population: Prognostic Implications
J. Yancey, E. Ko
2022International Journal of Radiation Oncology, Biology, Physics1 citations
Semantic Scholar
Stereotactic body radiation therapy for metastatic non-small cell lung cancer: a versatile treatment, repurposed
James L. Shen, E. Ko
2021Journal of Thoracic Disease1 citations Open access
Semantic Scholar
Breast Calcification Relative to Radiation Dose Distribution 21 years after Radiation Therapy: A Case Report and an Argument Against Hypofractionation of Breast Patients
Beth B. Herrick, M. Bishop-Jodoin, Ameer L. Elaimy, L. Shanmugham +26 more
2020Frontiers in Medical Case Reports1 citations
Semantic Scholar
Adenocarcinoma of the Prostate: Molecular Strategies for Improving the Therapeutic outcome for Radiation Therapy
Tao Wang, Brian E. Lewis, Marcus Ruscetti, E. Ko +2 more
2021Medical Research Archives0 citations Open access
Semantic Scholar
Radiation Therapy and Non-Hodgkin Lymphoma of the Extremity. Case Reports: Strategy for Treatment Planning and Therapy Implementation
Kevin C. O’Connor, James Shen, Ameer L. Elaimy, Rebecca Wang +26 more
2021Frontiers in Medical Case Reports0 citations Open access
Semantic Scholar
Analysis of Pathologic Complete Response 10 Weeks After Radiotherapy-A Radiobiological Sin.
E. Ko, Claire Vanpouille-Box, S. Formenti
2019JAMA Oncology0 citations
Semantic Scholar
Hyperprogressive disease on immune checkpoint therapy in advanced solid malignancies: A systematic review.
Xiao X. Wei, N. M. Chanzá, E. Ko, C. Mita +4 more
2019Journal of Clinical Oncology0 citations
Semantic Scholar
Eric Ko on Combining Radiation Therapy With Immunotherapy to Treat Non-Small-Cell Lung Cancer.
E. Ko
2018Oncology0 citations
Semantic Scholar
The Potential Impact of Medications on Biochemical Control Following Definitive Management of Prostate Cancer
S. Blacksburg, E. Ko, N. Stone, R. Stock
20120 citations Open access
Semantic Scholar
Association of Genetic Factors With PSA Response in Prostate Cancer Patients Receiving Definitive Radiation Therapy
E. Ko, S. Kerns, N. Stone, R. Stock +2 more
20120 citations
Semantic Scholar
Quality of Life With Adjuvant Radiation Therapy Following Transoral Robotic Surgery (TORS) for Head-and-Neck Cancer
T. Carpenter, Vishal Gupta, M. Buckstein, E. Ko +2 more
20120 citations Open access
Semantic Scholar
Adjusted Intermediate and High-Risk Stratification for Prostate Cancer Is More Prognostic Than Current NCCN Risk Grouping
Jerry Liu, E. Ko, S. Kerns, N. Stone +1 more
20120 citations Open access
Semantic Scholar
Early PSA Failure Time Following Brachytherapy Predicts for Decreased Prostate-Specific and Overall Survival
E. Ko, N. Stone, R. Stock
20110 citations
Semantic Scholar
PSA Nadir of <0.5 ng/mL following Brachytherapy for Early Stage Prostate Adenocarcinoma Predicts for Freedom From PSA Failure and Distant Metastasis
E. Ko, N. Stone, R. Stock
20100 citations
Semantic Scholar
CTL-Tumor Cell Interaction: The Generation of Molecular Probes Capable of Monitoring the HLA-A*0201-HER-2/neu Peptide Complex
E. Ko
20070 citations
Semantic Scholar
Dendritic cell-based approaches for the immunotherapy of malignant diseases
E. Ko
20060 citations
Semantic Scholar
Collaboration is required for successful immunotherapy
S. Ferrone, E. Ko
20060 citations
Semantic Scholar
Peptide Mimotope: Functional Effects Antigen-Specific Antibodies Elicited by a Molecular Weight-Melanoma Associated Targeting Melanoma Cells with Human High
Ferrone, W. Luo, E. Ko, Xin-Hui Wang
20060 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

J. Kao×9
Invite
J. Kao — researcher profile on SciRah
R. Stock×8
Invite
R. Stock — researcher profile on SciRah
Xin-Hui Wang×8
Invite
Xin-Hui Wang — researcher profile on SciRah
S. Ferrone×8
Invite
S. Ferrone — researcher profile on SciRah

×7

Invite

N. Stone — researcher profile on SciRah

Invite

S. Formenti — researcher profile on SciRah

Shu-Hsia Chen×6

Invite

Shu-Hsia Chen — researcher profile on SciRah

Invite

W. Luo — researcher profile on SciRah

Invite

E. Genden — researcher profile on SciRah

B. Rosenstein×5

Invite

B. Rosenstein — researcher profile on SciRah

Invite

S. Fu — researcher profile on SciRah

Vishal Gupta×4

Invite

Vishal Gupta — researcher profile on SciRah